Pill tested to fix dangerous blood cell drops after transplant
NCT ID NCT05502783
Summary
This study tested whether a pill called fostamatinib could help adults who developed dangerously low blood cell counts after a stem cell transplant. The goal was to see if taking the drug for 12 weeks could help stabilize red blood cell or platelet levels without needing frequent transfusions. The trial was terminated early after enrolling only one participant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC GVHD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Institutes of Health Clinical Center
Bethesda, Maryland, 20892, United States
Conditions
Explore the condition pages connected to this study.